02 Mar Scientists and advocates announce the formation of Odylia Therapeutics
Posted at 10:32h
in Press Releases
Odylia Therapeutics, a new nonprofit organization, will bring treatments to clinical trial for people at risk for blindness due to ultra-rare inherited retinal diseases. By leveraging our non-profit status and world-class expertise, we will bring forward therapies for indications which have been left behind by traditional for-profit mechanisms.